Ironwood to Pay $1B to Acquire VectivBio, Late-Stage Digestive Therapy
Data from a Phase III trial of apraglutide for a type of short bowel syndrome with intestinal failure is expected by the end of the year. It is also in a Phase II study for acute graft-versus-host disease.